Home
Home About Us Our Technology News + Media Investor Relations Contact Us
 
Investor Info
SEC Filings

XBRL Filings
Governance Documents
 

Investor Relations



CytoSorbents Investor Materials

CytoSorbents Shareholder Update Letter - November 2014

CytoSorbents Q3 2014 Conference Call - November 12, 2014
Official Transcript                Presentation                Webcast

CytoSorbents Q2 2014 Conference Call  -  August 12, 2014
Official Transcript                Presentation                Webcast

CytoSorbents Q1 2014 Conference Call    -    May 14, 2014
Official Transcript                Presentation                Webcast

CytoSorbents Fiscal 2013 Conference Call - March 31, 2014
Official Transcript                Presentation                Webcast

CytoSorbents Q3 2013 Conference Call - November 6, 2013
Official Transcript                Presentation                Webcast

CytoSorbents Executive Summary - November 2014

2014 Rodman & Renshaw Annual Global Investment Conference - September 3, 2014

The Wall Street Transcript Interview - August 2014

CytoSorbents 2013 Shareholder Letter - January 2014

CytoSorbents Marketing Material

CytoSorb Product Overview Brochure - January 2013

HemoDefend Product Overview Brochure - 2013

CytoSorbents Clinical and Scientific Data

Recent published case reports and studies on CytoSorb. Click on hyperlinked titles to download articles

CytoSorbents Analyst Coverage

Zacks - CTSO: Fresenius Adds More than Just Marketing Muscle - Dec 2014

Zacks - CTSO: Data Registry, Other Developments Bode Well for Increased Adoption - Nov 2014

Zacks - CTSO: Record Product Sales, Again. Data Supports Cardiac Surgery - August 2014

Zacks - CTSO: Record Product Sales. MERS Opportunity Is Promising - May 2014

Zacks - CTSO: Record Sales in Q4 But Even Bigger Plans for 2014 - April 2014

Zacks - CTSO: Product Sales Jump, Momentum Continues - November 2013

Zacks - CTSO: Tiny Med-Tech With Huge Potential - June 2013

Zacks Small Cap Research Initiation Report Link - June 2012

Brean Murray Research Reports
Email: avogel@cytosorbents.com

H.C. Wainwright Research Reports
Email: avogel@cytosorbents.com

Merriman Research Reports
Email: avogel@cytosorbents.com


CytoSorbents Media

Medical Device Daily - CytoSorb Cardiac Trial IDE Submitted - Dec 2014

Fierce Medical Devices - Fresenius and CytoSorbents Partner - Dec 2014

Fierce Drug Delivery - CytoSorbents Uplists to NASDAQ - Dec 2014

Prince William Recognizes CytoSorbents - Dec 2014

South Brunswick Post U.S. Representative Rush Holt Visit - Jan 2014

Biotech product geared toward reducing deaths in the ICU - Jan 2014

U.S.1 News Feature - July 2013

Frost & Sullivan Report - June 2013

Wall St. Analyst Interview with Dr. Phillip Chan - May 2013

MedCity News Report - May 2013

MedGadget Interview with Dr. Chan - April 2013

Medical Device Daily Cover Story - December 2012

MoneyTV Interview with Dr. Chan - August 2012

OneMedPlace 2012 Interview with Dr. Phillip Chan

For investor relations matters or questions please contact:
avogel@cytosorbents.com

CytoSorbents Medical Inc. is a wholly owned subsidary of CytoSorbents Corporation

 

 
Home | Career Opportunities | Contact Us
© 2014 CytoSorbents Corporation All Rights Reserved